
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Nov 14, 2025 02:01 am UTC| Business Health
Merck is reportedly close to finalizing a deal to acquire Cidara Therapeutics, offering a premium over the biotechnology companys current market value of about $3.3 billion. According to a report from the Financial Times,...

Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Nov 11, 2025 01:00 am UTC| Health Governance
Canada has lost its measles elimination status after nearly three decades, following a year-long outbreak that the Pan American Health Organization (PAHO) confirmed on Monday. The setback also affects the Americas region,...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Nov 10, 2025 13:44 pm UTC| Business Health Science
Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Nov 09, 2025 00:37 am UTC| Business Health
Pfizer has sealed a $10 billion acquisition of obesity drug developer Metsera, marking a major victory in the rapidly expanding weight-loss drug market. The New York-based pharmaceutical giant outbid Danish rival Novo...

Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Nov 08, 2025 01:48 am UTC| Business Health
Pfizer Inc. has reportedly increased its takeover offer for Metsera, a U.S.-based obesity drug developer, signaling its determination to outpace Danish rival Novo Nordisk in the lucrative weight-loss treatment market....

Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Nov 07, 2025 09:54 am UTC| Business Health
Shares in Novo Nordisk dropped nearly 3% on Friday after the Danish pharmaceutical giant and U.S. competitor Eli Lilly agreed to cut prices for their leading GLP-1 weight-loss drugs under a new deal with the U.S....

U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Nov 07, 2025 01:49 am UTC| Health Politics
A panel of independent U.S. vaccine experts has announced plans to review the long-standing recommendation for administering the hepatitis B vaccine at birth. The Vaccine Integrity Project, an organization focused on...